Pro: Lung transplantation should be routinely performed with cardiopulmonary bypass

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 14, Issue 6, 2000, Pages 739-745

  Marczin, Nándor ^a   Royston, David ^a   Yacoub, Magdi ^a  

^a HAREFIELD HOSPITAL   (United Kingdom)

Author keywords

Cardiopulmonary bypass; Complications; Lung transplantation; Outcomes; Respiratory failure

Indexed keywords

ANTIOXIDANT; APROTININ; CYTOKINE; PROTEINASE INHIBITOR;

CARDIOPULMONARY BYPASS; COMPLEMENT ACTIVATION; DISEASE ASSOCIATION; GRAFT FAILURE; HEART SURGERY; HUMAN; INFLAMMATION; INFLAMMATORY CELL; LUNG ENDOTHELIUM; LUNG FUNCTION; LUNG INJURY; LUNG INSUFFICIENCY; LUNG TRANSPLANTATION; NONHUMAN; OUTCOMES RESEARCH; OXYGENATOR; PATHOGENESIS; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; REVIEW; SURGICAL TECHNIQUE; TREATMENT INDICATION;

EID: 0033664367     PISSN: 10530770     EISSN: None     Source Type: Journal    
DOI: 10.1053/jcan.2000.18592     Document Type: Article

References (93)

1. Cardiopulmonary bypass is associated with early allograft dysfunction but not death after double-lung transplantation
2. Acute pulmonary edema after lung transplantation: The pulmonary reimplantation response
3. Lung transplant edema: Chest radiography after lung transplantation - The first 10 days
4. Primary graft failure following lung transplantation
5. Free radical-mediated tissue injury in acute lung allograft rejection and the effect of superoxide dismutase
6. Vitamin C reduces ischaemia-reperfusion-induced acute lung injury
7. Ischemia-reperfusion injury to the lung
8. Aprotinin therapy in heart and heart-lung transplantation
9. Recombinant Kunitz protease inhibitor ameliorates reperfusion injury in rat lung transplantation
10. Addition of aprotinin to organ preservation solutions decreases lung reperfusion injury
11. Reversal of ischemia/reperfusion lung injury by inhibition of polymorphonuclear leukocytes
12. Antisense intercellular adhesion molecule-1 (ICAM-1) oligodeoxyribonucleotide delivered during organ preservation inhibits posttransplant ICAM-1 expression and reduces primary lung isograft failure
13. Amelioration of lung reperfusion injury by L- and E-selectin blockade
14. Reduced neutrophil infiltration protects against lung reperfusion injury after transplantation
15. Reperfusion conditions: Importance of ensuring gentle versus sudden reperfusion during relief of coronary occlusion
16. Efficacy of initial controlled perfusion pressure for ischemia-reperfusion injury in a 24-hour preserved lung
17. Controlled reperfusion prevents pulmonary injury after 24 hours of lung preservation
18. Controlled reperfusion protects lung grafts during a transient early increase in permeability
19. Critical importance of the first 10 minutes of lung graft reperfusion after hypothermic storage
20. The therapeutic potential of nitric oxide in lung transplantation
21. Relative importance of prostaglandin/cyclic adenosine monophosphate and nitric oxide/cyclic guanosine monophosphate pathways in lung preservation
22. Lung transplantation: Historical perspective, current concepts, and anesthetic considerations
23. Technical aspects of adult lung transplantation
24. Predictors, frequency, and indications for cardiopulmonary bypass during lung transplantation in adults
25. Preoperative prediction for the use of cardiopulmonary bypass in lung transplantation
26. Anesthesia for bilateral sequential lung transplantation: Experience of 64 cases
27. Results of single and bilateral lung transplantation in 131 consecutive recipients
28. Double-lung transplantation for cystic fibrosis
29. Bilateral single-lung transplantation in children
30. Pediatric and adult lung transplantation for cystic fibrosis
31. Lung injury and acute respiratory distress syndrome after cardiopulmonary bypass
32. Prevalence of acute respiratory distress syndrome after cardiac surgery
33. Adult respiratory distress syndrome following cardiopulmonary bypass: Incidence and prediction
34. Adult respiratory distress syndrome after cardiac surgery
35. Delayed pleuropulmonary complications following coronary artery revascularization with the internal mammary artery
36. Pulmonary alveolar lesions following open heart surgery: An electron microscopic study
37. Phrenic nerve function and its relationship to atelectasis after coronary artery bypass surgery
38. Coronary artery bypass grafting using two different anesthetic techniques: Part 2. Postoperative outcome
39. Perioperative morbidity in patients randomized to epidural or general anesthesia for lower extremity vascular surgery
40. Assessment of lung injury in the adult respiratory distress syndrome using multiple indicator dilution curves
41. Failure of aerosolised 99mTc DTPA clearance to predict outcome in patients with adult respiratory distress syndrome
42. Does PEEP facilitate the resolution of extravascular lung water after experimental hydrostatic pulmonary oedema?
43. Acute lung injury during cardiopulmonary bypass, the role of neutrophil sequestration and lipid peroxidation
44. Management of adult respiratory distress syndrome
45. Complement and the damaging effects of cardiopulmonary bypass
46. Complement activation during cardiopulmonary bypass: Evidence for generation of C3a and C5a anaphylatoxins
47. Complement and the damaging effects of cardiopulmonary bypass
48. Biologically active products of complement and acute lung injury in patients with the sepsis syndrome
49. Complement and neutrophil activation during cardiopulmonary bypass: A study in the complement-deficient dog
50. Complement activation during extracorporeal circulation: In vitro comparison of Duraflo II heparin-coated and uncoated oxygenator circuits
51. Circulating cytokines and granulocyte-derived enzymes during complex heart surgery: A clinical study with special reference to heparin coating of cardiopulmonary bypass circuits
52. Specific complement inhibition with heparin-coated extracorporeal circuits
53. Attenuation of changes in leukocyte surface markers and complement activation with heparin-coated cardiopulmonary bypass
54. Deleterious effects of cardiopulmonary bypass on early graft function after single-lung allotransplantation: Evaluation of a heparin-coated bypass circuit
55. Heparinized cardiopulmonary bypass and full heparin dose marginally improve clinical performance
56. Mechanisms of the systemic inflammatory response
57. The influence of cardiopulmonary bypass on cytokines and cell-cell communication
58. Cardiopulmonary bypass-induced inflammation: Is it important?
59. Cytokine responses to cardiopulmonary bypass: Lessons learned from cardiac transplantation
60. The balance of pro- and anti-inflammatory cytokines in plasma and bronchoalveolar lavage (BAL) at paediatric cardiac surgery
61. Cytokine balance and immunosuppressive changes at cardiac surgery: Contrasting response between patients and isolated CPB circuits
62. New strategies for combatting sepsis: The magic bullets missed the mark . . . But the search continues
63. Selected treatment strategies for septic shock based on proposed mechanisms of pathogenesis
64. Nuclear factor-kB - A pivotal transcription factor in chronic inflammatory diseases
65. In vitro NF-kappaB activation as a bioassay to monitor cardiopulmonary bypass-induced systemic inflammatory response
66. Marginated pool of neutrophils in rabbit lungs
67. The effect of cigarette smoking on neutrophil kinetics in human lungs
68. Effect of raised alveolar pressure on leukocyte retention in the human lung
69. Effect of positive end-expiratory pressure on leukocyte transit in rabbit lungs
70. Mechanical properties of HL60 cells: Role of stimulation and differentiation in retention in capillary-sized pores
71. Mechanisms of lipopolysaccharide-induced neutrophil retention: Relative contributions of adhesive and cellular mechanical properties
72. Mechanics of stimulated neutrophils: Cell stiffening induces retention in capillaries
73. Endothelial response to cardiopulmonary bypass surgery
74. Organ dysfunction and cardiopulmonary bypass: The role of complement and complement regulatory proteins
75. Complement activation, cytokines, and adhesion molecules in children undergoing cardiac surgery with or without cardiopulmonary bypass
76. Changes in leukocyte counts and soluble intercellular adhesion molecule-1 and E-selectin during cardiopulmonary bypass in children
77. Expression of soluble endothelial adhesion molecules in clinical cardiopulmonary bypass
78. Soluble adhesion molecules in infants and children undergoing cardiopulmonary bypass
79. Nitric oxide in exhaled air is a new marker of airway inflammation
80. Exhaled nitric oxide in patients undergoing cardiothoracic surgery: A new diagnostic tool?
81. Measurement of endogenous nitric oxide in the lungs of patients with the acute respiratory distress syndrome
82. Exhaled nitric oxide during lung transplantation
83. Basal release of EDRF in oxidant stress conditions
84. Intravenous nitrate vasodilators and exhaled nitric oxide [2]
85. Production of nitric oxide during surgery involving cardiopulmonary bypass
86. Loss of nitrovasodilator-induced exhaled NO as a marker of lung injury during transplantation
87. Analysis of 10-year experience with heart-lung transplantation for cystic fibrosis
88. Long-term results of heart-lung transplantation for pulmonary hypertension
89. Long-term results of combined heart-lung transplantation: The Stanford experience
90. Lung transplantation
91. Effect of cardiopulmonary bypass on early graft dysfunction in clinical lung transplantation
92. Lung transplantation for cystic fibrosis
93. Extracorporeal perfusion